PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

46 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Wang, J. et al.: Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer. Br. J. Cancer 130, 1036-1045 (2024)
2.
Hvidtfeldt, U.A.* et al.: Long-term air pollution exposure and malignant intracranial tumours of the central nervous system: A pooled analysis of six European cohorts. Br. J. Cancer 129, 656-664 (2023)
3.
Lorenzini, T.* et al.: Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy. Br. J. Cancer 129, 696-705 (2023)
4.
Pisula, J.I.* et al.: Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks. Br. J. Cancer 128, 1369-1376 (2023)
5.
Chen, J.* et al.: Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: The ELAPSE project. Br. J. Cancer 126, 1499-1507 (2022)
6.
Flach, S.* et al.: Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma. Br. J. Cancer 126, 1186–1195 (2022)
7.
Mukama, T.* et al.: Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer. Br. J. Cancer (2022)
8.
Seifert, M.* et al.: Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function. Br. J. Cancer 127, 2175-2185 (2022)
9.
Jesinghaus, M.* et al.: Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma. Br. J. Cancer 122, 835-846 (2020)
10.
Jesinghaus, M.* et al.: Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma. Br. J. Cancer 121, 1050-1057 (2019)
11.
Summerer, I. et al.: Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br. J. Cancer 113, 76-82 (2015)
12.
Malinowsky, K.* et al.: Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer. Br. J. Cancer 110, 2081-2089 (2014)
13.
Wyler, L.* et al.: Brain metastasis in renal cancer patients: Metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. Br. J. Cancer 110, 686-694 (2014)
14.
Enciso-Mora, V.* et al.: Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br. J. Cancer 108, 2178-2185 (2013)
15.
Falkenberg, N. et al.: MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion. Br. J. Cancer 109, 2714-2723 (2013)
16.
Gross, E.* et al.: Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers. Br. J. Cancer 109, 2347-2355 (2013)
17.
Rohrmann, S.* et al.: Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br. J. Cancer 108, 708-714 (2013)
18.
Slotta-Huspenina, J.* et al.: A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas. Br. J. Cancer 109, 370-378 (2013)
19.
Buck, K.* et al.: Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. Br. J. Cancer 105, 1151-1157 (2011)
20.
Aubele, M. et al.: In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues. Br. J. Cancer 103, 663-667 (2010)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮